CCP
IDXX icon

Clough Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Clough Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,481
Closed -$1.24M – 158
2020
Q4 		$1.24M Hold
2,481
– – 0.09% 96
2020
Q3 		$975K Hold
2,481
– – 0.07% 93
2020
Q2 		$819K Sell
2,481
-2,000
-45% -$579K 0.08% 108
2020
Q1 		$1.08M Sell
4,481
-25,704
-85% -$6.71M 0.11% 77
2019
Q4 		$7.88M Buy
30,185
+8,170
+37% +$2.15M 0.67% 53
2019
Q3 		$5.99M Buy
22,015
+4,785
+28% +$1.33M 0.5% 47
2019
Q2 		$4.74M Sell
17,230
-8,290
-32% -$2.04M 0.47% 69
2019
Q1 		$5.71M Buy
+25,520
New +$5.27M 0.5% 67

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Clough Capital Partners's IDXX Position: Q1 2021 in Review

Clough Capital Partners sold out of Idexx Laboratories (IDXX) in Q1 2021, closing a stake of 2,481 shares — an estimated $1.24M sold.

Clough Capital Partners first reported a position in IDXX in Q1 2019 and held it in 8 quarters. The position peaked at $7.88M in Q4 2019. 1,012 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.

  • Clough Capital Partners reported no remaining Idexx Laboratories position as of Q1 2021 after selling out during the quarter.
  • Clough Capital Partners sold 2,481 Idexx Laboratories shares in Q1 2021, an estimated $1.24M.
  • Clough Capital Partners first reported a position in Idexx Laboratories in Q1 2019 and held it in 8 quarters.
  • Clough Capital Partners's Idexx Laboratories position peaked at $7.88M in Q4 2019.
  • 1,012 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.

Based on Clough Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.